A61K 2039/55588
Adjuvants of undefined constitution
Official title: {Adjuvants of undefined constitution}
A61K2039/55588 (Adjuvants of undefined constitution) appears on 466 US grants and 691 published applications in this corpus.
Search patents in A61K- Granted patents
- 466
- Published applications
- 691
- Assignees
- 417
- Inventors
- 1,418
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 9 | 1 |
| 2002 | 7 | 7 |
| 2003 | 4 | 18 |
| 2004 | 3 | 20 |
| 2005 | 5 | 29 |
| 2006 | 3 | 16 |
| 2007 | 5 | 7 |
| 2008 | 15 | 22 |
| 2009 | 13 | 18 |
| 2010 | 22 | 29 |
| 2011 | 7 | 25 |
| 2012 | 11 | 16 |
| 2013 | 10 | 25 |
| 2014 | 14 | 16 |
| 2015 | 20 | 37 |
| 2016 | 18 | 38 |
| 2017 | 23 | 45 |
| 2018 | 30 | 34 |
| 2019 | 37 | 49 |
| 2020 | 33 | 36 |
| 2021 | 30 | 48 |
| 2022 | 22 | 45 |
| 2023 | 18 | 36 |
| 2024 | 21 | 28 |
| 2025 | 22 | 20 |
| 2026 | 10 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Klebsiella vaccine and methods of use11 Aug 2026US 12,702,704 B2Cornell University
- Gut bacteria derived microvesicles for vaccine delivery16 Jun 2026US 12,653,877 B2Quadram Institute Bioscience
- Click outer membrane vesicles16 Jun 2026US 12,653,882 B2Intravacc B.V.
- Bacterial membrane vesicles, and separation and preparation system and method therefor9 Jun 2026US 12,648,990 B2Sichuan University
- Nucleic acid nanostructure platform for programming immune stimulation2 Jun 2026US 12,642,850 B2Massachusetts Institute of Technology
- Methods and compositions for targeted delivery by polymersomes24 Sep 2026US 2026/0284198 A1Rock Biomedical, Inc.
- Plasmacytoid dendritic cells for treating cancer17 Sep 2026US 2026/0272977 A1Pdc Line Pharma
- Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis27 Aug 2026US 2026/0248874 A1Poly Gain Pte Ltd
- Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases6 Aug 2026US 2026/0224687 A1Centre National De La Recherche Scientifique
- Tumor-targeting pharmaceutical combinations30 Jul 2026US 2026/0216257 A1Baccine Ltd.
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Vaccine containing tumor antigens and adjuvants126US 4,877,611 ARibi ImmunoChem Research, Inc. · 1989
- Cytophaga-derived immunopotentiator119US 4,978,622 AThe Regents of the University of California · 1990
- Composition for inducing proliferation or accumulation of regulatory T cells98US 9,808,519 B2The University of Tokyo · 2017
- Composition for inducing proliferation or accumulation of regulatory T cells85US 9,662,381 B2The University of Tokyo · 2017